because every day counts
Vitara Biomedical is a medical technology company reinventing the standard of care for extremely premature newborns
Reinventing Neonatal Care
Every year, nearly one million premature newborns face life-threatening challenges. Less than half of babies born before 25 weeks survive, and most survivors face severe, lifelong complications. Vitara Biomedical is reinventing the standard of care with groundbreaking Neonatal Support Technology designed to give extremely premature infants born as early as 22 weeks a better chance to survive and thrive.
01
Born Too Soon
Premature birth is one of the world’s greatest unmet challenges. Nearly one million infants die each year from complications of being born too soon. Babies arriving halfway to term have lungs and organs not ready for air, yet the standard of care has barely advanced in decades.
02
The Current Gap
Fewer than half of babies born before 25 weeks survive, and most who do face lifelong complications affecting the lungs, heart, or brain. Each child can cost more than $1 million in NICU care, adding up to billions annually, while incubators still cannot prevent fragile lungs from breathing air too soon.
03
A Safer Bridge
NeST, Vitara’s Neonatal Support Technology, offers a natural, fluid-filled environment similar to the womb for up to 28 days. This breakthrough provides precious time for vital organs to grow before babies transition to standard care, with the potential to reduce mortality by 80% and long-term complications by 45%.
ABOUT US
Vitara Biomedical is a medical technology company reinventing the standard of care for extremely premature newborns, less than half of whom survive today.
Our Neonatal Support Technology (NeST) system, also known as EXTEND, surrounds newborns in a natural, fluid-filled environment for 28 days, delaying the stress of early air exposure until their fragile lungs and other vital organs are more developed. Our technology could reduce mortality by 80% and long-term complications by 45%.
Vitara's
Transformational Technology
Vitara is creating the next generation platform therapy for preterm infants.
01
Fluid-Filled Care
Provides a protective, nurturing environment that shields fragile lungs and supports natural organ growth during therapy.
02
Biologically Inspired
Modeled on natural fetal physiology, NeST mirrors the conditions of the womb—offering a true alternative beyond traditional incubators.
03
The Gift of Time
Extends the window for development, allowing premature newborns to continue growing safely until their bodies are stronger and more prepared.
04
Next-Generation Platform
Represents a groundbreaking leap in neonatal medicine, setting a new standard of care for the tiniest and most vulnerable patients.
05
Biocompatible by Design
Constructed with high-grade biocompatible materials to ensure safety, compatibility, and trust in every detail.
“The impact of this technology will be life changing. It will be a new paradigm in pediatrics.”
Dr. Alan Flake,
Co-Inventor & Vitara Medical Advisor
Life-Saving Impact
Survival Odds
Less than half of babies born before 25 weeks survive today. NeST offers a new chance to change these odds.
Better Outcomes
Our technology could reduce mortality by up to 80% and lifelong complications by up to 45%.
28-Day Bridge
EXTEND provides up to 28 days of protection, helping infants reach the stage where survival rates climb to nearly 90%.